Literature DB >> 7479316

Isolation and characterization of ovokinin, a bradykinin B1 agonist peptide derived from ovalbumin.

H Fujita1, H Usui, K Kurahashi, M Yoshikawa.   

Abstract

A vasorelaxing peptide was purified from a peptic digest of ovalbumin, after three steps of reverse-phase HPLC. The structure of the peptide was Phe-Arg-Ala-Asp-His-Pro-Phe-Leu, which corresponded to residues 358-365 of ovalbumin. The peptide was named ovokinin. Ovokinin showed relaxing activity for a canine mesenteric artery (EC50 = 6.3 microM). The relaxing activity was blocked by the bradykinin B1 antagonist [des-Arg9] [Leu8]bradykinin, but not by the B2 antagonist Hoe 140. Ovokinin binds to B1 receptors (IC50 = 64 microM). Prostaglandin I2 was released from the artery after ovokinin stimulation as a relaxing factor. Thus, ovokinin is a weak bradykinin B1 agonist peptide derived from food proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479316     DOI: 10.1016/0196-9781(95)00054-n

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

Review 1.  Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis.

Authors:  Simone Marcone; Orina Belton; Desmond J Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  2016-06-17       Impact factor: 4.335

Review 2.  Food-derived bioactive peptides on inflammation and oxidative stress.

Authors:  Subhadeep Chakrabarti; Forough Jahandideh; Jianping Wu
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

3.  Gastrointestinal Endogenous Protein-Derived Bioactive Peptides: An in Vitro Study of Their Gut Modulatory Potential.

Authors:  Lakshmi A Dave; Maria Hayes; Leticia Mora; Carlos A Montoya; Paul J Moughan; Shane M Rutherfurd
Journal:  Int J Mol Sci       Date:  2016-04-01       Impact factor: 5.923

4.  Vasorelaxing and antihypertensive activities of synthesized peptides derived from computer-aided simulation of pepsin hydrolysis of yam dioscorin.

Authors:  Yin-Shiou Lin; Yeh-Lin Lu; Guei-Jane Wang; Hong-Jen Liang; Wen-Chi Hou
Journal:  Bot Stud       Date:  2014-06-07       Impact factor: 2.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.